Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency

Jocelyn R Farmer 1Zsofia Foldvari 2Boglarka Ujhazi 3Suk See De Ravin 4Karin Chen 5Jack J H Bleesing 6Catharina Schuetz 7Waleed Al-Herz 8Roshini S Abraham 9Avni Y Joshi 10Beatriz T Costa-Carvalho 11David Buchbinder 12Claire Booth 13Andreas Reiff 14Polly J Ferguson 15Asghar Aghamohammadi 16Hassan Abolhassani 16Jennifer M Puck 17Mehdi Adeli 18Caterina Cancrini 19Paolo Palma 20Alice Bertaina 21Franco Locatelli 22Gigliola Di Matteo 19Raif S Geha 23Maria G Kanariou 24Lilia Lycopoulou 25Marianna Tzanoudaki 24John W Sleasman 26Suhag Parikh 27Gloria Pinero 26Bernard M Fischer 26Ghassan Dbaibo 28Ekrem Unal 29Turkan Patiroglu 30Musa Karakukcu 29Khulood Khalifa Al-Saad 31Meredith A Dilley 32Sung-Yun Pai 33Cullen M Dutmer 34Erwin W Gelfand 35Christoph B Geier 36Martha M Eibl 37Hermann M Wolf 38Lauren A Henderson 39Melissa M Hazen 39Carmem Bonfim 40Beata Wolska-Kuśnierz 41Manish J Butte 42Joseph D Hernandez 43Sarah K Nicholas 44Polina Stepensky 45Shanmuganathan Chandrakasan 46Maurizio Miano 47Emma Westermann-Clark 48Vera Goda 49Gergely Kriván 49Steven M Holland 50Olajumoke Fadugba 51Sarah E Henrickson 52Ahmet Ozen 53Elif Karakoc-Aydiner 53Safa Baris 53Ayca Kiykim 54Robbert Bredius 55Birgit Hoeger 56Kaan Boztug 57Olga Pashchenko 58Benedicte Neven 59Despina Moshous 60Jean-Pierre de Villartay 61Ahmed Aziz Bousfiha 62Harry R Hill 63Luigi D Notarangelo 47Jolan E Walter 64

Affiliations


Abstract

Background: Although autoimmunity and hyperinflammation secondary to recombination activating gene (RAG) deficiency have been associated with delayed diagnosis and even death, our current understanding is limited primarily to small case series.

Objective: Understand the frequency, severity, and treatment responsiveness of autoimmunity and hyperinflammation in RAG deficiency.

Methods: In reviewing the literature and our own database, we identified 85 patients with RAG deficiency, reported between 2001 and 2016, and compiled the largest case series to date of 63 patients with prominent autoimmune and/or hyperinflammatory pathology.

Results: Diagnosis of RAG deficiency was delayed a median of 5 years from the first clinical signs of immune dysregulation. Most patients (55.6%) presented with more than 1 autoimmune or hyperinflammatory complication, with the most common etiologies being cytopenias (84.1%), granulomas (23.8%), and inflammatory skin disorders (19.0%). Infections, including live viral vaccinations, closely preceded the onset of autoimmunity in 28.6% of cases. Autoimmune cytopenias had early onset (median, 1.9, 2.1, and 2.6 years for autoimmune hemolytic anemia, immune thrombocytopenia, and autoimmune neutropenia, respectively) and were refractory to intravenous immunoglobulin, steroids, and rituximab in most cases (64.7%, 73.7%, and 71.4% for autoimmune hemolytic anemia, immune thrombocytopenia, and autoimmune neutropenia, respectively). Evans syndrome specifically was associated with lack of response to first-line therapy. Treatment-refractory autoimmunity/hyperinflammation prompted hematopoietic stem cell transplantation in 20 patients.

Conclusions: Autoimmunity/hyperinflammation can be a presenting sign of RAG deficiency and should prompt further evaluation. Multilineage cytopenias are often refractory to immunosuppressive treatment and may require hematopoietic cell transplantation for definitive management.

Keywords: Autoimmune cytopenias; Hematopoietic stem cell transplantation (HSCT); Immune dysregulation; Recombination activating gene (RAG); Severe combined immunodeficiency (SCID).

Conflict of interest statement

Conflict of Interest Disclosures

The authors have no conflicts of interest to disclose regarding the content of this paper.


Figures


Similar articles

Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency.

Geier CB, Farmer JR, Foldvari Z, Ujhazi B, Steininger J, Sleasman JW, Parikh S, Dilley MA, Pai SY, Henderson L, Hazen M, Neven B, Moshous D, Sharapova SO, Mihailova S, Yankova P, Naumova E, Özen S, Byram K, Fernandez J, Wolf HM, Eibl MM, Notarangelo LD, Calabrese LH, Walter JE.Front Immunol. 2020 Oct 21;11:574738. doi: 10.3389/fimmu.2020.574738. eCollection 2020.PMID: 33193364 Free PMC article.

Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency.

John T, Walter JE, Schuetz C, Chen K, Abraham RS, Bonfim C, Boyce TG, Joshi AY, Kang E, Carvalho BT, Mahajerin A, Nugent D, Puthenveetil G, Soni A, Su H, Cowan MJ, Notarangelo L, Buchbinder D.J Clin Immunol. 2016 Oct;36(7):725-32. doi: 10.1007/s10875-016-0326-x. Epub 2016 Aug 18.PMID: 27539235 Free PMC article. Review.

Combined Autoimmune Cytopenias Presenting in Childhood.

Al Ghaithi I, Wright NA, Breakey VR, Cox K, Warias A, Wong T, O'Connell C, Price V.Pediatr Blood Cancer. 2016 Feb;63(2):292-8. doi: 10.1002/pbc.25769. Epub 2015 Sep 23.PMID: 26397379

DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.

Al-Herz W, Massaad MJ, Chou J, Notarangelo LD, Geha RS.Clin Immunol. 2018 Feb;187:68-75. doi: 10.1016/j.clim.2017.10.006. Epub 2017 Oct 16.PMID: 29051008 Free PMC article.

Primary immunodeficiencies (PIDs) presenting with cytopenias.

Notarangelo LD.Hematology Am Soc Hematol Educ Program. 2009:139-43. doi: 10.1182/asheducation-2009.1.139.PMID: 20008192 Review.


Cited by

[Principles of the diagnostics of inborn errors of immunity].

Geier CB, Voll RE, Warnatz K.Z Rheumatol. 2023 May;82(4):285-297. doi: 10.1007/s00393-023-01351-4. Epub 2023 Apr 20.PMID: 37079035 Review. German.

Granulomatous inflammation in inborn errors of immunity.

Sacco KA, Gazzin A, Notarangelo LD, Delmonte OM.Front Pediatr. 2023 Feb 20;11:1110115. doi: 10.3389/fped.2023.1110115. eCollection 2023.PMID: 36891233 Free PMC article. Review.

Refractory, fatal autoimmune hemolytic anemia due to ineffective thymic-derived T-cell reconstitution following allogeneic hematopoietic cell transplantation for hypomorphic RAG1 deficiency.

Yonkof JR, Basu A, Redmond MT, Dobbs AK, Perelygina L, Notarangelo LD, Abraham RS, Rangarajan HG.Pediatr Blood Cancer. 2023 May;70(5):e30183. doi: 10.1002/pbc.30183. Epub 2022 Dec 30.PMID: 36583469 No abstract available.

Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT.

Schuetz C, Gerke J, Ege M, Walter J, Kusters M, Worth A, Kanakry JA, Dimitrova D, Wolska-Kuśnierz B, Chen K, Unal E, Karakukcu M, Pashchenko O, Leiding J, Kawai T, Amrolia PJ, Berghuis D, Buechner J, Buchbinder D, Cowan MJ, Gennery AR, Güngör T, Heimall J, Miano M, Meyts I, Morris EC, Rivière J, Sharapova SO, Shaw PJ, Slatter M, Honig M, Veys P, Fischer A, Cavazzana M, Moshous D, Schulz A, Albert MH, Puck JM, Lankester AC, Notarangelo LD, Neven B.Blood. 2023 Feb 16;141(7):713-724. doi: 10.1182/blood.2022017667.PMID: 36279417

Targeted treatment of autoimmune cytopenias in primary immunodeficiencies.

Pacillo L, Giardino G, Amodio D, Giancotta C, Rivalta B, Rotulo GA, Manno EC, Cifaldi C, Palumbo G, Pignata C, Palma P, Rossi P, Finocchi A, Cancrini C.Front Immunol. 2022 Aug 16;13:911385. doi: 10.3389/fimmu.2022.911385. eCollection 2022.PMID: 36052091 Free PMC article. Review.


KMEL References